Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg)

Buy Tesamorelin CJC-1295 Ipamorelin – Advanced Growth Hormone Research Blend

Buy Tesamorelin CJC-1295 Ipamorelin blend which combines three research peptides designed to target the growth hormone (GH) axis through distinct but complementary mechanisms. Tesamorelin and CJC-1295 engage GHRH receptors in the pituitary, while Ipamorelin selectively activates ghrelin (GHS) receptors, collectively stimulating endogenous GH release.

How the Blend Works

• Tesamorelin: A synthetic GHRH analogue, Tesamorelin binds to pituitary GHRH receptors, potentially enhancing GH secretion. Modifications at the N-terminus (acetyl group) and C-terminus (trans-3-hexenoic acid) may improve peptide stability and resistance to enzymatic breakdown.
• CJC-1295 (Mod GRF 1-29): A tetrasubstituted GHRH peptide designed for a prolonged half-life, CJC-1295 may stimulate GH secretion while resisting degradation. It can covalently bind to albumin in the blood, extending its duration of action.
• Ipamorelin: A selective ghrelin receptor agonist, Ipamorelin may trigger GH release with high specificity and minimal impact on other hormones. It also interacts with the GI tract to potentially enhance gut motility and nutrient absorption.
• Synergistic Action: The combination of these peptides is thought to amplify GH release beyond what any single peptide can achieve, potentially promoting lean muscle growth, fat reduction, bone strength, metabolism optimization, and improved recovery.

Potential Research Applications

Pituitary & GH Axis Studies

• Engages both GHRH and GHS receptors to enhance pulsatile GH release.
• Tesamorelin and CJC-1295 may stimulate intracellular cAMP-PKA signaling pathways, leading to HGH secretion and subsequent IGF-1 production.
• Ipamorelin may activate PLC/IP3/DAG signaling cascades to trigger GH exocytosis.

Muscle & Bone Research

• Tesamorelin and Ipamorelin have shown potential to increase muscle density and size in specific muscle groups.
• CJC-1295 may support lean mass gain, IGF-1 elevation, and improved insulin sensitivity.
• Early studies suggest potential bone density benefits, making this blend valuable in musculoskeletal research.

Metabolic & Lipid Research

• GH release may influence lipolysis, visceral fat reduction, and lipid metabolism.
• May enhance insulin sensitivity and glucose utilization, relevant in metabolic disorder studies.

Digestive Function & Appetite Research

• When you Buy Tesamorelin CJC-1295 Ipamorelin, it may increase gastric motility, accelerate gastric emptying, and support nutrient absorption.
• Possible effects on appetite and energy regulation provide avenues for metabolic and gastrointestinal studies.

Cognitive & Recovery Research

• GH and IGF-1 may impact neuroplasticity, cognitive performance, and recovery processes.
• The blend is ideal for studies exploring GH-related effects on overall physiological and neurological health.

Chemical Profile

Tesamorelin

• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Molecular Weight: 5136 g/mol
• Other Names: N-(trans-3-hexenoyl)-[Tyr1]hGRF(1–44)NH2 acetate

CJC-1295 (Mod GRF 1-29)

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3367.9 g/mol
• Other Names: CJC 1295 with DAC

Ipamorelin

• Molecular Formula: C₃₈H₄₉N₉O₅
• Molecular Weight: 711.8 g/mol
• Other Names: Ipamorelin Acetate